1. Home
  2. INZY vs TWIN Comparison

INZY vs TWIN Comparison

Compare INZY & TWIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INZY
  • TWIN
  • Stock Information
  • Founded
  • INZY 2015
  • TWIN 1918
  • Country
  • INZY United States
  • TWIN United States
  • Employees
  • INZY N/A
  • TWIN N/A
  • Industry
  • INZY Biotechnology: Pharmaceutical Preparations
  • TWIN Industrial Machinery/Components
  • Sector
  • INZY Health Care
  • TWIN Industrials
  • Exchange
  • INZY Nasdaq
  • TWIN Nasdaq
  • Market Cap
  • INZY 256.3M
  • TWIN 97.0M
  • IPO Year
  • INZY 2020
  • TWIN N/A
  • Fundamental
  • Price
  • INZY N/A
  • TWIN $9.68
  • Analyst Decision
  • INZY Buy
  • TWIN Strong Buy
  • Analyst Count
  • INZY 9
  • TWIN 1
  • Target Price
  • INZY $15.22
  • TWIN $12.00
  • AVG Volume (30 Days)
  • INZY 989.2K
  • TWIN 158.3K
  • Earning Date
  • INZY 08-05-2025
  • TWIN 08-14-2025
  • Dividend Yield
  • INZY N/A
  • TWIN 1.65%
  • EPS Growth
  • INZY N/A
  • TWIN N/A
  • EPS
  • INZY N/A
  • TWIN 0.29
  • Revenue
  • INZY N/A
  • TWIN $328,478,000.00
  • Revenue This Year
  • INZY N/A
  • TWIN $27.91
  • Revenue Next Year
  • INZY N/A
  • TWIN N/A
  • P/E Ratio
  • INZY N/A
  • TWIN $33.23
  • Revenue Growth
  • INZY N/A
  • TWIN 11.49
  • 52 Week Low
  • INZY $0.72
  • TWIN $6.16
  • 52 Week High
  • INZY $6.24
  • TWIN $14.98
  • Technical
  • Relative Strength Index (RSI)
  • INZY 82.67
  • TWIN 72.97
  • Support Level
  • INZY $3.94
  • TWIN $8.67
  • Resistance Level
  • INZY $3.97
  • TWIN $9.88
  • Average True Range (ATR)
  • INZY 0.01
  • TWIN 0.55
  • MACD
  • INZY -0.08
  • TWIN 0.13
  • Stochastic Oscillator
  • INZY 100.00
  • TWIN 91.84

About INZY Inozyme Pharma Inc.

Inozyme Pharma Inc is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting bone health and blood vessel function. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies. Its product candidate, INZ-701, is a soluble, recombinant, genetically engineered fusion protein that is designed to correct a defect in a pathway involving ENPP1 and ABCC6 deficiencies.

About TWIN Twin Disc Incorporated

Twin Disc Inc is a United States-based firm engaged in the manufacture and sale of marine and heavy-duty off-highway power transmission equipment. The company operates its business through two reportable segments: Manufacturing and Distribution. Its product portfolio includes marine transmissions, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, and control systems.

Share on Social Networks: